Frailty index and phenotypic age jointly predict mortality in NHANES adults
In 20,089 NHANES adults followed a median 11.8 years, higher frailty index and faster phenotypic aging each were associated with higher all-cause mortality; the frail-accelerated aging group had the highest risk. [1]
Automatic summary · not editorially reviewed
The key findings
The prospective cohort used NHANES data from four survey cycles (2003-2010) and mortality records until December 31, 2019. [1]
Among 20,089 adults followed a median 11.8 years, 3,778 deaths occurred; each 1 SD higher frailty index was associated with 47% higher all-cause mortality risk. [1]
The frail-accelerated aging group had the highest all-cause mortality risk (HR 5.32, 95% CI 4.50-6.29) versus robust-decelerated aging; adding both measures improved prediction. [1]
The source at a glance
- Study type / format
- Prospective cohort study (abstract)
- Population / context
- 20,089 adults in NHANES survey cycles 2003-2010 with mortality follow-up.
- Summary based on
- Study abstract
- Original publication
- June 13, 2026
Frailty index and phenotypic age in NHANES adults
This prospective cohort used NHANES data from four survey cycles (2003 to 2010) with mortality records through December 31, 2019. The frailty index was calculated from each participant's responses to 34 questions. PhenoAge was derived from algorithms using nine biomarkers and chronological age. The authors describe both as independent indicators of biological age and asked whether they jointly or interactively predict death risk.
Supporting source [1]
Higher frailty and faster aging linked to mortality
Among 20,089 adults with a median follow-up of 11.8 years, 3,778 deaths were documented. Each 1 standard deviation increment in frailty index was associated with 47% (42%-51%) higher all-cause mortality risk, and each 1 SD increment in PhenoAgeAccel with 41% (38%-45%) higher risk. A multiplicative interaction on death risk was not found (P = 0.054). Compared with the robust-decelerated aging reference group, the frail-accelerated aging group had the highest all-cause mortality risk, with a hazard ratio of 5.32 (95% CI 4.50-6.29).
Supporting source [1]
Prediction gain and abstract-only scope
Adding both frailty index and PhenoAgeAccel to the traditional model improved predictive accuracy (C-index 0.882 vs. 0.866, continuous net reclassification index 46.18%, integrated discrimination improvement 4.10%). The authors conclude that jointly including both measures better predicts individual death risk and suggest that targeting their components may reduce death risk and prolong health span. These are associations from an observational cohort, not evidence that changing either measure causes longer life. This explainer is based on the abstract only; the full text was not reviewed.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. This is an observational cohort, so the reported associations do not show that frailty index or phenotypic age cause death, and the authors' suggestion about targeting their components is not tested here.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Shao Z, Zhao Y, Yang H, Xiao M, Song M, Liao C, Pang Y, Gao W, Huang T, Yu C, Li S, Qi L, Li L, Lv J, Sun D. · europepmc.org · June 13, 2026